Ming-Hua Duan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ming-Hua Duan has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Qiao Gao
Changchun Univ Chinese Med, Changchun 130117, Jilin, Peoples R China
3 shared publicationsDa-Yan Xu
Changchun University of Chinese Medicine, Changchun 130117, Jilin, China
2 shared publicationsDong Han
School of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun, Jilin 130107, P.R. China
2 shared publicationsHe Lin
School of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun, Jilin 130107, P.R. China
2 shared publicationsTian-Yi Zhao
2 shared publicationsWen-Feng Zhang
Changchun University of Chinese Medicine, Changchun 130117, Jilin, China
2 shared publications
Latest Publications
- RetractionOpen Access
- 26 November 2025
- Published by Spandidos Publications in Oncology Letters
- Vol. 31 (2) , 1
[Retracted] Scutellarein suppresses Aβ‑induced memory impairment via inhibition of the NF‑κB pathway in vivo and in vitro
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
- 26 November 2025
- Published by Spandidos Publications in Oncology Letters
- Vol. 31 (2) , 1
RetractionOpen Access[Retracted] Scutellarein suppresses Aβ‑induced memory impairment via inhibition of the NF‑κB pathway in vivo and in vitro
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
- Open Access
- 6 March 2020
- Published by ResearchersLinks Ltd in Pakistan Journal of Zoology
- Vol. 52 (3) , 1031-1038
Biatractylolide Reduced Amyloid Beta Protein-Induced Memory Impairment in Rats
Biatractylolide Reduced Amyloid Beta Protein-Induced Memory Impairment in Rats
- 6 March 2020
- Published by ResearchersLinks Ltd in Pakistan Journal of Zoology
- Vol. 52 (3) , 1031-1038
Open AccessBiatractylolide Reduced Amyloid Beta Protein-Induced Memory Impairment in Rats
Biatractylolide Reduced Amyloid Beta Protein-Induced Memory Impairment in Rats
- Open Access
- 1 July 2019
- Published by ResearchersLinks Ltd in Pakistan Journal of Zoology
- Vol. 51 (5) , 1927-1935
Recovery of Chemotherapy-induced Anemia by Angelica Polysaccharides in C57BL/6N Mice and Elucidation of Underlying Mechanism
- 1 July 2019
- Published by ResearchersLinks Ltd in Pakistan Journal of Zoology
- Vol. 51 (5) , 1927-1935
Open AccessRecovery of Chemotherapy-induced Anemia by Angelica Polysaccharides in C57BL/6N Mice and Elucidation of Underlying Mechanism
- RetractedOpen Access
- 18 April 2019
- Published by Spandidos Publications in Oncology Letters
- Vol. 17 (6) , 5581-5589
Scutellarein suppresses Aβ‑induced memory impairment via inhibition of the NF‑κB pathway in vivo and in vitro
The flavonoid compound scutellarin (Scu) is a traditional Chinese medicine used to treat a variety of diseases; however, the use of scutellarein (Scue), the hydrolysate of Scu, and its mechanisms of action in Alzheimer's disease (AD) have not been fully elucidated. In the present study, the effects of Scue on amyloid β (Aβ)‑induced AD‑like pathology were investigated. An in vitro model of inflammation and an aged rat model were used to confirm the effects of Scue. In vitro MTT assays and flow cytometry were used to assess the effects of Scue on cell viability and apoptosis, respectively. A Morris water maze was used to evaluate spatial learning and memory, and the levels of Aβ deposition, superoxide dismutase, malondialdehyde, apoptosis, neuro‑inflammatory factors and nuclear factor‑κB (NF‑κB) activation in hippocampal tissues in vivo were measured to determine the effect of Scue in AD. Scue may be protective, as it decreased the apoptosis of hippocampal cells in vitro, inhibited Aβ‑induced cognitive impairment, suppressed hippocampal neuro‑inflammation and suppressed activation of NF‑κB in vivo. Therefore, Scue may be a useful agent for the treatment of Aβ‑associated pathology in the central nervous system through inhibition of the protein kinase B/NF‑κB signaling pathway and thus, future studies are required to investigate the efficacy of Scue in patients with AD.
- 18 April 2019
- Published by Spandidos Publications in Oncology Letters
- Vol. 17 (6) , 5581-5589
RetractedOpen AccessScutellarein suppresses Aβ‑induced memory impairment via inhibition of the NF‑κB pathway in vivo and in vitro
The flavonoid compound scutellarin (Scu) is a traditional Chinese medicine used to treat a variety of diseases; however, the use of scutellarein (Scue), the hydrolysate of Scu, and its mechanisms of action in Alzheimer's disease (AD) have not been fully elucidated. In the present study, the effects of Scue on amyloid β (Aβ)‑induced AD‑like pathology were investigated. An in vitro model of inflammation and an aged rat model were used to confirm the effects of Scue. In vitro MTT assays and flow cytometry were used to assess the effects of Scue on cell viability and apoptosis, respectively. A Morris water maze was used to evaluate spatial learning and memory, and the levels of Aβ deposition, superoxide dismutase, malondialdehyde, apoptosis, neuro‑inflammatory factors and nuclear factor‑κB (NF‑κB) activation in hippocampal tissues in vivo were measured to determine the effect of Scue in AD. Scue may be protective, as it decreased the apoptosis of hippocampal cells in vitro, inhibited Aβ‑induced cognitive impairment, suppressed hippocampal neuro‑inflammation and suppressed activation of NF‑κB in vivo. Therefore, Scue may be a useful agent for the treatment of Aβ‑associated pathology in the central nervous system through inhibition of the protein kinase B/NF‑κB signaling pathway and thus, future studies are required to investigate the efficacy of Scue in patients with AD.
- Open Access
- 11 February 2019
- Published by EDP Sciences in MATEC Web of Conferences
- Vol. 267, 03001
Determination of the Correction Factor for Dinalmefene Hydrochloride in Nalmefene Hydrochloride Injection
Objective: To calculate the detection correction factor for the impurity, that is, the dinalmefene hydrochloride in nalmefene hydrochloride injection. Methods: High performance liquid chromatography (HPLC) is used to analyze the impurities of nalmefene hydrochloride easily produced during storage, and the impurity is determined and correction factor is calculated for the known the dinalmefene hydrochloride. According to the standard curve method, the sample concentration is selected between the detection limit and the limit of quantification, and the standard curve is prepared. The correction factor is then calculated according to the slope of the standard curve. Results: finally, the correction factor for dinalmefene hydrochloride is 0.22. Conclusions: the correction factor calculated by the standard curve method is accurate and reliable, and can be used for impurity detection of nalmefene hydrochloride injection.
- 11 February 2019
- Published by EDP Sciences in MATEC Web of Conferences
- Vol. 267, 03001
Open AccessDetermination of the Correction Factor for Dinalmefene Hydrochloride in Nalmefene Hydrochloride Injection
Objective: To calculate the detection correction factor for the impurity, that is, the dinalmefene hydrochloride in nalmefene hydrochloride injection. Methods: High performance liquid chromatography (HPLC) is used to analyze the impurities of nalmefene hydrochloride easily produced during storage, and the impurity is determined and correction factor is calculated for the known the dinalmefene hydrochloride. According to the standard curve method, the sample concentration is selected between the detection limit and the limit of quantification, and the standard curve is prepared. The correction factor is then calculated according to the slope of the standard curve. Results: finally, the correction factor for dinalmefene hydrochloride is 0.22. Conclusions: the correction factor calculated by the standard curve method is accurate and reliable, and can be used for impurity detection of nalmefene hydrochloride injection.
- 1 September 2017
- Published by Elsevier in Phytomedicine
- Vol. 33, 21-27
Angelica polysaccharides inhibit the growth and promote the apoptosis of U251 glioma cells in vitro and in vivo
- 1 September 2017
- Published by Elsevier in Phytomedicine
- Vol. 33, 21-27
Angelica polysaccharides inhibit the growth and promote the apoptosis of U251 glioma cells in vitro and in vivo
- Open Access
- 1 January 2016
- Published by Medknow in Saudi Journal of Gastroenterology
- Vol. 22 (6) , 448-455
Deoxyschizandrin suppresses dss-induced ulcerative colitis in mice
Background/Aims: Deoxyschizandrin as one of the most important component of Schisandra chinensis (Turcz.) Baill plays an immunomodulatory role in a variety of diseases, yet its role in ulcerative colitis remains to be elucidated. We aimed to investigate the role of deoxyschizandrin in DSS-induced ulcerative colitis in mice. Patients and Methods: In the present study, an inflammation model of cells was constructed to confirm the anti-inflammatory effect of deoxyschizandrin. Then a mouse model with Dextran sulfate sodium sulfate (DSS)-induced ulcerative colitis was constructed, and the effects of deoxyschizandrin on mouse colon inflammation, apoptosis, and CD4 T lymphocyte infiltration in ulcerative colitis were examined. Result: Deoxyschizandrin could improve the symptoms of ulcerative colitis, determined by hematoxylin-eosin (HE) staining and histopathological scores. Moreover, deoxyschizandrin reduced the levels of inflammatory cytokines, suppressed CD4 T cell infiltration, and effectively inhibited apoptosis in the colon of DSS-induced ulcerative colitis mice. Conclusion: In summary, deoxyschizandrin can effectively rescue the symptoms of DSS-induced ulcerative colitis in mice by inhibiting inflammation. T cell infiltration and apoptosis in the colon, suggesting that deoxyschizandrin could be a potential drug in treating ulcerative colitis.
- 1 January 2016
- Published by Medknow in Saudi Journal of Gastroenterology
- Vol. 22 (6) , 448-455
Open AccessDeoxyschizandrin suppresses dss-induced ulcerative colitis in mice
Background/Aims: Deoxyschizandrin as one of the most important component of Schisandra chinensis (Turcz.) Baill plays an immunomodulatory role in a variety of diseases, yet its role in ulcerative colitis remains to be elucidated. We aimed to investigate the role of deoxyschizandrin in DSS-induced ulcerative colitis in mice. Patients and Methods: In the present study, an inflammation model of cells was constructed to confirm the anti-inflammatory effect of deoxyschizandrin. Then a mouse model with Dextran sulfate sodium sulfate (DSS)-induced ulcerative colitis was constructed, and the effects of deoxyschizandrin on mouse colon inflammation, apoptosis, and CD4 T lymphocyte infiltration in ulcerative colitis were examined. Result: Deoxyschizandrin could improve the symptoms of ulcerative colitis, determined by hematoxylin-eosin (HE) staining and histopathological scores. Moreover, deoxyschizandrin reduced the levels of inflammatory cytokines, suppressed CD4 T cell infiltration, and effectively inhibited apoptosis in the colon of DSS-induced ulcerative colitis mice. Conclusion: In summary, deoxyschizandrin can effectively rescue the symptoms of DSS-induced ulcerative colitis in mice by inhibiting inflammation. T cell infiltration and apoptosis in the colon, suggesting that deoxyschizandrin could be a potential drug in treating ulcerative colitis.